Back to Search
Start Over
Embecta diabetes spin-off approved by BD board
- Source :
- Chain Drug Review. March 14, 2022, Vol. 44 Issue 5, p35, 2 p.
- Publication Year :
- 2022
-
Abstract
- FRANKLIN LAKES, N.J. -- The board of BD last month approved the planned spin-off of its diabetes care business, which will be known as embecta, and declared a pro rata [...]
- Subjects :
- Becton, Dickinson and Co. -- Subsidiaries, divisions and units
Medical test kit industry -- Subsidiaries, divisions and units
Medical equipment and supplies industry -- Subsidiaries, divisions and units
Spinoff company
Company business management
Business
Pharmaceuticals and cosmetics industries
Retail industry
Subjects
Details
- Language :
- English
- ISSN :
- 01649914
- Volume :
- 44
- Issue :
- 5
- Database :
- Gale General OneFile
- Journal :
- Chain Drug Review
- Publication Type :
- Periodical
- Accession number :
- edsgcl.696858494